Clinical Trial Update: Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary efficacy of the combination of duvelisib and nivolumab in patients with Richter syndrome or transformed fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Richter Syndrome
• Small Lymphocytic Lymphoma
• Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-cell Lymphoma
• Transformed Follicular Lymphoma to Diffuse Large B-cell Lymphoma
• Transformed Small Lymphocytic Lymphoma to Diffuse Large B-cell Lymphoma

Drugs mentioned

• Duvelisib (duvelisib)
• nivolumab (nivolumab)

Snippet

Sponsor: David Bond, MD | Conditions: Chronic Lymphocytic Leukemia, Recurrent Diffuse Large B-Cell Lymphoma | Phase 1 | Status: COMPLETED